22 Stocks Moving In Monday's Pre-Market Session

Gainers

  • Novocure Ltd NVCR rose 40.1 percent to $11.35 in pre-market trading after the company disclosed that the two-year survival rate for GBM Patients increased from 30% to 43% for patients treated with Optune + temozolomide versus temozolomide alone at the AACR 2017.
  • Steadymed Ltd STDY shares rose 31 percent to $7.60 in pre-market trading. Cardiome's partner SteadyMed received a favorable ruling in USPTO Inter Partes Review in validity of U.S. Patent No. 8,497,393.
  • Cellect Biotechnology Ltd. APOP rose 15.6 percent to $9.94 in pre-market trading after the company reported an European patent grant.
  • Dynavax Technologies Corporation DVAX rose 15.1 percent to $6.85 in pre-market trading after the company disclosed that the PDUFA date for HEPLISAV-B will remain unchanged.
  • BioCryst Pharmaceuticals, Inc. BCRX shares rose 9.6 percent to $9.21 in pre-market trading after the company reported that Mundipharma has received approval for Mundesine in Japan.
  • BiondVax Pharmaceuticals Ltd (ADR) BVXV rose 9.5 percent to $6.35 in pre-market trading after declining 6.90 percent on Friday.
  • Eleven Biotherapeutics Inc EBIO rose 9.1 percent to $2.40 in pre-market trading. Eleven Biotherapeutics presented new preclinical data supporting potential of the company's locally and systematically-administered drug candidates at the AACR 2017.
  • Infinity Pharmaceuticals Inc. INFI rose 8.4 percent to $3.50 in pre-market trading. Infinity Pharmaceuticals presented updated Phase 1 data for IPI-549 at the AACR 2017.
  • Matinas BioPharma Holdings Inc MTNB rose 8.3 percent to $3.00 in pre-market trading. Matinas BioPharma reported a FY16 loss of $0.21 per share.
  • Medigus Ltd. MDGS shares rose 7.1 percent to $3.30 in pre-market trading after dropping 3.14 percent on Friday.
  • AerCap Holdings N.V. AER rose 6.3 percent to $48.86 in pre-market trading after gaining 0.13 percent on Friday.
  • Kite Pharma Inc KITE rose 5.8 percent to $83.01 in pre-market trading. Kite presented ongoing response rate in plenary session from its pivotal CAR-T trial of Axicabtagene Ciloleucel in patients with aggressive non-hodgkin lymphoma at AACR 2017.
  • Nabors Industries Ltd. NBR shares rose 5.1 percent to $13.74 in pre-market trading after gaining 0.15 percent on Friday.
  • Syneron Medical Ltd. ELOS shares rose 4.7 percent to $11.05 in pre-market trading. Syneron Candela agreed to be acquired by funds advised by Apax Partners for $11 per share in cash,

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

  • United Therapeutics Corporation UTHR dropped 9.1 percent to $123.00 in pre-market trading after the company disclosed that the US launch of RemoSynch will be delayed due to regulatory delays.
  • Acorda Therapeutics Inc ACOR shares fell 5 percent to $19.95 in the pre-market trading session after declining 21.50 percent on Friday.
  • Dicerna Pharmaceuticals Inc DRNA shares fell 4.4 percent to $3.25 in pre-market trading after climbing 25.93 percent on Friday.
  • Conatus Pharmaceuticals Inc CNAT fell 3 percent to $5.60 in pre-market trading after declining 2.53 percent on Friday.
  • DRDGOLD Ltd. (ADR) DRD fell 2.7 percent to $4.78 in pre-market trading after rising 1.87 percent on Friday.
  • DBV Technologies SA - ADR DBVT shares fell 2.4 percent to $34.39 in pre-market trading after gaining 1.00 percent on Friday.
  • Accenture Plc ACN fell 2.2 percent to $117.22 in pre-market trading. Goldman Sachs downgraded Accenture from Neutral to Sell and lowered the price target from $125.00 to $110.00.
  • Deutsche Bank AG (USA) DB fell 2.1 percent to $16.81 in pre-market trading after dropping 0.58 percent on Friday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsMovers#PreMarket GainersEnergyLosersOil & Gas DrillingTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!